Shopping Cart
- Remove All
- Your shopping cart is currently empty
ZM600 is an effective and orally active anti-hepatic fibrosis agent that can reduce the protein expression of collagen I, α-SM, and p-p65. This compound shows promising potential for use in hepatic fibrosis research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | ZM600 is an effective and orally active anti-hepatic fibrosis agent that can reduce the protein expression of collagen I, α-SM, and p-p65. This compound shows promising potential for use in hepatic fibrosis research. |
In vitro | ZM600 exhibits cytotoxic effects on LX-2 cells with an IC50 value of 38.17 µM. ZM600 (0, 5, 10, 20 µM; 2+48 h) reduces the protein and mRNA expression of collagen I and α-SM induced by LPS and TGF-β1. Additionally, ZM600 (0, 5, 10, 20 µM; 2+2 h) diminishes the expression of p-p65, p-Smad2/3, and p-AKT proteins in LX-2 cells triggered by LPS and TGF-β1. |
In vivo | ZM600, administered orally at doses of 15 and 30 mg/kg daily for a period of three weeks, was found to alleviate CCl4-induced experimental liver fibrosis. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.